XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments FINANCIAL INSTRUMENTS
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities
As of December 31, 2020 and 2021, our cash, cash equivalents, restricted cash, and marketable securities primarily consisted of cash, AAA-rated money market funds, U.S. and foreign government and agency securities, other investment grade securities, and marketable equity securities. Cash equivalents and marketable securities are recorded at fair value. The following table summarizes, by major security type, our cash, cash equivalents, restricted cash, and marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in millions):
 December 31, 2020
  
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Total
Estimated
Fair Value
Cash$10,063 $— $— $10,063 
Level 1 securities:
Money market funds27,430 — — 27,430 
Equity securities (1)617 
Level 2 securities:
Foreign government and agency securities5,130 — 5,131 
U.S. government and agency securities7,410 30 (1)7,439 
Corporate debt securities29,684 305 (1)29,988 
Asset-backed securities3,206 32 (3)3,235 
Other fixed income securities701 — 710 
Equity securities (1)40 
$83,624 $377 $(5)$84,653 
Less: Restricted cash, cash equivalents, and marketable securities (2)(257)
Total cash, cash equivalents, and marketable securities$84,396 
 December 31, 2021
  
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Total
Estimated
Fair Value
Cash$10,942 $— $— $10,942 
Level 1 securities:
Money market funds20,312 — — 20,312 
Equity securities (1)1,646 
Level 2 securities:
Foreign government and agency securities181 — — 181 
U.S. government and agency securities4,316 (25)4,300 
Corporate debt securities35,810 75 (121)35,764 
Asset-backed securities6,763 (32)6,738 
Other fixed income securities688 (4)686 
Equity securities (1)(3)15,740 
$79,012 $93 $(182)$96,309 
Less: Restricted cash, cash equivalents, and marketable securities (2)(260)
Total cash, cash equivalents, and marketable securities$96,049 
___________________
(1)The related unrealized gain (loss) recorded in “Other income (expense), net” was $4 million, $448 million, and $11.6 billion for the years ended December 31, 2019, 2020, and 2021.
(2)We are required to pledge or otherwise restrict a portion of our cash, cash equivalents, and marketable fixed income securities primarily as collateral for real estate, amounts due to third-party sellers in certain jurisdictions, debt, and standby and trade letters of credit. We classify cash, cash equivalents, and marketable fixed income securities with use restrictions of less than twelve months as “Accounts receivable, net and other” and of twelve months or longer as non-current “Other assets” on our consolidated balance sheets. See “Note 7 — Commitments and Contingencies.”
(3)Our equity investment in Rivian of $15.6 billion reflects a discount for lack of marketability until Q1 2022 due to regulatory sales restrictions. In addition, we are subject to contractual sales restrictions until Q2 2022.
The following table summarizes gross gains and gross losses realized on sales of marketable fixed income securities (in millions):
Year Ended December 31,
201920202021
Realized gains$11 $92 $85 
Realized losses56 38 
The following table summarizes the remaining contractual maturities of our cash equivalents and marketable fixed income securities as of December 31, 2021 (in millions):
Amortized
Cost
Estimated
Fair Value
Due within one year$39,070 $39,075 
Due after one year through five years22,790 22,712 
Due after five years through ten years2,124 2,121 
Due after ten years4,086 4,073 
Total$68,070 $67,981 
Actual maturities may differ from the contractual maturities because borrowers may have certain prepayment conditions.
Consolidated Statements of Cash Flows Reconciliation
The following table provides a reconciliation of the amount of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows (in millions):
December 31, 2020December 31, 2021
Cash and cash equivalents$42,122 $36,220 
Restricted cash included in accounts receivable, net and other233 242 
Restricted cash included in other assets22 15 
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows$42,377 $36,477